InvestorsHub Logo
Followers 35
Posts 1202
Boards Moderated 1
Alias Born 08/27/2000

Re: sulaco post# 302396

Wednesday, 07/12/2017 12:39:57 PM

Wednesday, July 12, 2017 12:39:57 PM

Post# of 345861

AntiPs, would bind to an antigen's epitope, the paratope could become the epitope for another antibody that will then bind to it.. This would be an example of cross reactivity.. What are the consequences of this in relation to Bavituximab's binding, and potency (immunomodulatory effect) ??

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=126554281

The song remains the same.

All the best,
John


Disclaimer: Every post, and all my views are only speculative. Do not invest money or any other resources based on these post or opinions. Best of luck and do your own due diligence!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News